Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
A Case Study Providing a Potential Link Between Long-COVID and Vestibular Symptoms
The case report, Relative Brain Perfusion Differences in a Patient with Persistent Neurocognitive and Vestibular Symptoms Associated with Post-COVID-19 Condition: A Case Report (Pham, 2026), describes…
Utility of Rotary Chair Testing
In a recent article, Advances in the Clinical Application of Rotational Chair Testing for the Diagnosis and Management of Vestibular Disorders (Ganggang et al., 2026), the…
Congress Averts Government Shutdown Through December
The House voted 370–48 to approve a stopgap funding bill that would keep the federal government operating through December 11, averting a government shutdown before…



